Let's talk medical research

Obesity is a common condition, impacting nearly 3 in 4 adults over the age of 20 in the United States. Research into obesity medications has increased significantly in recent years, resulting in novel weight-management drugs that are continuing to drive interest and demand. However, although obesity disproportionately impacts people of color, many of these studies are still made up of ...

Enabling medical advancements is one of Antidote’s chief missions, and one way we do this is through our robust partner network. By providing our clinical trial search tool, Antidote Match, to these organizations at no cost, we can build relationships with condition experts, reach patient communities effectively, and aid individuals during their search for clinical trials.

In the latest installment of Talk of the Towne, we sat down with Melanie Paris, M.A., MPH, the Senior Director of Strategic Partnerships and Kidney Disease Education at the American Kidney Fund (AKF). In the discussion, we got her insights into the types of kidney disease, treatment disparities, and the importance of clinical research in the field. She also shared many valuable resources for ...

Obesity, a medical condition characterized by an increased amount of body fat, impacts nearly 3 in 4 adults over the age of 20 in the United States. Most commonly defined as a Body Mass Index (BMI) over 30, it is a chronic condition that can negatively impact many aspects of a person’s health.

Obesity, a condition that impacts 2 out of 5 adults in the United States, has become a significant health concern, both due to the impacts it has on individuals with the condition and the effect it can have on the overall medical system. It is estimated that obesity is responsible for nearly $1.73 billion in excess treatment costs annually, compounded by the fact that individuals with obesity are ...

When determining which clinical trial is the right fit, many factors must be considered. The site location, the number of required visits, and the length of the study are all important considerations, but before any of this, it is vital to consider the study's inclusion and exclusion criteria.

Before any new treatment is able to be approved, it is required to go through the vigorous testing process known as clinical trials. These trials are aimed at determining whether or not a drug, medical device, therapy, or other type of intervention is safe and effective for the public.

Though clinical trials are often discussed in the context of medications and therapies, the devices that administer these medications must also be approved by the FDA before they can be released to market. This requirement includes tools patients and medical professionals use, such as inhalers, insulin injectors, auto-injectors for epinephrine, and devices that administer injectable medications.

When recruiting patients for a clinical trial, using data is one of the best ways to make informed decisions about study management. From understanding where patients are in the funnel to which sites are receiving too much volume, accessing the metrics that drive these decisions should be simple — and with Antidote’s Pulse™ software, it is.

Antidote was thrilled to attend the 2024 DIA Conference in San Diego last week! Not only was it a lovely opportunity to connect with many industry professionals and learn from experts, but it was also the celebration of 60 years of DIA. In case you missed it, we’re sharing some of our key takeaways from the four-day event, which focused on charting new horizons in clinical trials.